Forum Topic: Mitochondrial Biomarkers and Therapeutic Targets

View topics list | Add post

Mitochondrial Biomarkers and Therapeutic Targets

Mitochondria are the key to ATP production in almost all cell types. Since mitochondria do not contain histone, the methylation/hydroxymethylation rate of mitochondria may be more important than histone modification. The epigenetic modification sites of mtDNA mainly include the methylation of whole and some specific fragments of genes. Epigenetic modification of mitochondrial-specific abnormal sites can be used in clinical tumor therapy and prevention strategies of some related diseases. As a new biological marker, mtDNA epigenetic products are used to detect related diseases, including cancer, neurodegenerative diseases, and age-related diseases. [url]https://www.mitochondriasci.com/biomarkers-and-therapeutic-targets.html[/url]

This topic was started by Joe Cohen.

No user comments.

View topics list | Add post